SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...

Thank you, Almog. Since joining Lifeward Ltd. in June, I have completed a sober and comprehensive assessment of the business, ...

Expands Mechanical Capabilities in the Northern Virginia/DC Metro Area with One of the Leading Contractors for the Data ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

India’s defence-shipbuilding cycle is shifting gears, as a new set of contenders gains attention with swelling order books ...

AES offers deep-value at 6.5x earnings with a 5% yield, strong renewables pipeline, long-term PPAs, growing EPS, and utility ...

Origin Materials, Inc. ("Origin," "Origin Materials," or the "Company") (Nasdaq: ORGN, ORGNW), a technology company with a mission to enable the world’s transition to sustainable materials, today ...

Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase ...

SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker ...

Metalla Royalty & Streaming announces its operating and financial results for the three and nine months ended Sept 30, 2025. For complete details of the condensed interim consolidated financial ...

ESI delves into Honor of Kings' global esports approach and its lofty ambitions to create a competitor outside of China.

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing ...